Biomarkers of Clinician Burnout
- PMID: 33904028
- PMCID: PMC8810959
- DOI: 10.1007/s11606-021-06757-x
Biomarkers of Clinician Burnout
Conflict of interest statement
EAL is on the scientific advisory board and has a financial interest in OXT Therapeutics, a company developing an intranasal oxytocin and long-acting analogs of oxytocin to treat obesity and metabolic disease. EAL’s interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies. All other authors report no declarations of interest.
References
-
- Zak P. The Neuroscience of Trust. Harv Bus Rev. 2017;95(1):84–90.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
